Your browser doesn't support javascript.
loading
Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease.
Falkevall, Annelie; Mehlem, Annika; Palombo, Isolde; Heller Sahlgren, Benjamin; Ebarasi, Lwaki; He, Liqun; Ytterberg, A Jimmy; Olauson, Hannes; Axelsson, Jonas; Sundelin, Birgitta; Patrakka, Jaakko; Scotney, Pierre; Nash, Andrew; Eriksson, Ulf.
Affiliation
  • Falkevall A; Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Mehlem A; Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Palombo I; Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Heller Sahlgren B; Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Ebarasi L; Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden; Department of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Uppsala University, 751 85 Uppsala, Sweden; Division of Renal Medicine, Department of Clinical Scie
  • He L; Department of Immunology, Genetics, and Pathology, Rudbeck Laboratory, Uppsala University, 751 85 Uppsala, Sweden.
  • Ytterberg AJ; Division of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden; Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, 171 76 Stockholm, Sweden.
  • Olauson H; Division of Renal Medicine, Department of Clinical Sciences, Intervention, and Technology, Karolinska Institutet, 141 86 Stockholm, Sweden.
  • Axelsson J; Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden; Center for Apheresis and Stem Cell Handling, Karolinska University Hospital, 141 86 Stockholm, Sweden.
  • Sundelin B; Department of Oncology-Pathology, Karolinska Institutet and Karolinska University Hospital, 171 76 Stockholm, Sweden.
  • Patrakka J; KI/AZ Integrated CardioMetabolic Center (ICMC), Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, 141 57 Huddinge, Sweden.
  • Scotney P; CSL Limited, Parkville, VIC 3052, Australia.
  • Nash A; CSL Limited, Parkville, VIC 3052, Australia.
  • Eriksson U; Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden. Electronic address: ulf.pe.eriksson@ki.se.
Cell Metab ; 25(3): 713-726, 2017 03 07.
Article in En | MEDLINE | ID: mdl-28190774
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Vascular Endothelial Growth Factor B / Diabetic Nephropathies / Kidney / Lipids Type of study: Prognostic_studies Language: En Journal: Cell Metab Journal subject: METABOLISMO Year: 2017 Document type: Article Affiliation country: Sweden Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Vascular Endothelial Growth Factor B / Diabetic Nephropathies / Kidney / Lipids Type of study: Prognostic_studies Language: En Journal: Cell Metab Journal subject: METABOLISMO Year: 2017 Document type: Article Affiliation country: Sweden Country of publication: United States